11β-Hydroxysteroid dehydrogenase type 1 inhibition protects against the development of adverse metabolic and bone effects of prednisolone: A randomized, double-blind, placebo-controlled trial.

European Society of Endocrinology
9/7/20, 5:00 PM
Europe/Paris GMT+2

Description

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

Inglês

 

Speakers

Nantia Othonos